Claudio B.
- Country
- Italy
- Department
- -
Research Overview
- Evaluation of ISIS 678354 Sodium Salt in Patients with Severe Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
- Phase 3 Multicenter Study on Lorundrostat Efficacy and Safety in Uncontrolled and Resistant Hypertension
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Olezarsen (ISIS 678354) in Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease
Data & Insights
Has run more than one trial at 45 of 315 partner sites.
Specializations
Cardiovascular Disease Management
The investigator specializes in treating complex cardiovascular conditions, with particular emphasis on atherosclerotic cardiovascular disease and its prevention.
- Cardiovascular event prevention
- Management of vascular diseases
- Heart failure treatment
The research focus includes innovative approaches to reducing cardiovascular mortality and improving outcomes in patients with reduced ejection fraction.
Hypertension Research
Expertise in treating complex forms of hypertension, particularly focusing on patients with uncontrolled and resistant hypertension.
- Novel antihypertensive therapies
- Blood pressure management strategies
- Long-term blood pressure control
Specialized interest in developing therapeutic solutions for patients who don't respond to conventional treatments.
Lipid Disorders
Deep involvement in treating severe hypertriglyceridemia and related metabolic disorders, with focus on innovative therapeutic approaches.
- Triglyceride level management
- Lipoprotein disorders
- Metabolic condition treatment
The research encompasses new therapeutic modalities for managing complex lipid disorders and their cardiovascular complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.